Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy.

Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS.

J Am Acad Child Adolesc Psychiatry. 1989 Sep;28(5):777-84.

PMID:
2676967
2.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
3.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
4.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
5.

Another sudden death in a child treated with desipramine.

Riddle MA, Geller B, Ryan N.

J Am Acad Child Adolesc Psychiatry. 1993 Jul;32(4):792-7. Review.

PMID:
8340300

Supplemental Content

Support Center